首页> 外国专利> Use of the HAb18G / CD147 molecule as a target for antiviral antagonists and the antiviral antagonists thus obtained

Use of the HAb18G / CD147 molecule as a target for antiviral antagonists and the antiviral antagonists thus obtained

机译:HAb18G / CD147分子用作抗病毒拮抗剂的靶标以及由此获得的抗病毒拮抗剂

摘要

The present invention relates to use of HAb 18G/CD 147 molecule as target for designing antiviral antagonist and the antiviral antagonist designed by using such molecule, especially antagonist against SARS Coronavirus and AIDS virus HIV-1. Antagonist of the present invention includes antibody, polypeptide, immune complex, derivative, small molecule compound and so on, which is able to prevent SARS Coronavirus and AIDS virus (HIV-1) from invading host cell, thereby exerts its antagonistic antiviral effect. It is provided by in vitro experiment that such antagonist has inhibitory effect against SARS Coronavirus and AIDS virus (HIV-1), thus is potential antiviral candidate drug.
机译:本发明涉及HAb 18G / CD 147分子作为设计抗病毒拮抗剂的靶标的用途,以及使用该分子设计的抗病毒拮抗剂,特别是针对SARS冠状病毒和AIDS病毒HIV-1的拮抗剂。本发明的拮抗剂包括抗体,多肽,免疫复合物,衍生物,小分子化合物等,它们能够防止SARS冠状病毒和AIDS病毒(HIV-1)侵入宿主细胞,从而发挥其拮抗抗病毒作用。通过体外实验表明,该拮抗剂对SARS冠状病毒和AIDS病毒(HIV-1)具有抑制作用,因此是潜在的抗病毒候选药物。

著录项

  • 公开/公告号JP2006525946A

    专利类型

  • 公开/公告日2006-11-16

    原文格式PDF

  • 申请/专利权人 陳 志南;

    申请/专利号JP20040571759

  • 发明设计人 陳 志南;

    申请日2003-06-09

  • 分类号A61K45;A61K38;A61K39/395;A61P31/12;A61P31/18;A61P11;

  • 国家 JP

  • 入库时间 2022-08-21 21:08:34

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号